Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25269041 | 0.85 | — | — | |
| SCHEMBL2015595 | 0.85 | — | — | |
| SCHEMBL1330919 | 0.83 | — | — | |
| SCHEMBL23785 | 0.83 | — | — | |
| SCHEMBL22878567 | 0.81 | — | — | |
| SCHEMBL6368222 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL8669936 | 0.81 | — | — | |
| Nitrogen SCHEMBL15994321 | 0.79 | ALDH1A1 (0.90) | ALDH1A1KMT2AESR1 | |
| Methyl Alcohol SCHEMBL28312507 | 0.79 | ALDH1A1 (0.90) | ALDH1A1KMT2AESR1 | |
| Nitrous Acid SCHEMBL14660251 | 0.77 | ALDH1A1 (0.86) | ALDH1A1KMT2AESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240285549-A1 | CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF | CONSTANCE THERAPEUTICS, INC. (US) | 2024-08-29 | — | — | US | disclosed |
| US-20240033312-A1 | CANNABIS OIL EXTRACTS AND COMPOSITIONS | CONSTANCE THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | US | disclosed |
| US-11596618-B2 | Oral cannabinoid delivery formulations with mouthfeel experience enhancers | Resurgent Biosciences, Inc. (US) | 2023-03-07 | — | — | US | disclosed |
| US-20220331344-A1 | ORAL FORMULATIONS OF PSYCHOTROPIC MACROFUNGUS BOTANICAL EXTRACTS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CHICAGO ATLANTIC ADMIN, LLC | 2022-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240033312-A1 | CANNABIS OIL EXTRACTS AND COMPOSITIONS | CNR2, CNR1, DNER | ALDH1A1 1885/4885KMT2A 3448/4885ESR1 784/4885 |
| US-20240285549-A1 | CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF | CNR1, CNR2, PROC | ALDH1A1 1486/4885KMT2A 3580/4885ESR1 1107/4885 |
| US-20220331344-A1 | ORAL FORMULATIONS OF PSYCHOTROPIC MACROFUNGUS BOTANICAL EXTRACTS WITH MOUTHFEEL EXPERIENCE ENHANCERS | MB, MLEC, NISCH | ALDH1A1 3594/4885KMT2A 4605/4885ESR1 4415/4885 |
| US-11596618-B2 | Oral cannabinoid delivery formulations with mouthfeel experience enhancers | CNR2, CNR1, CPNE4 | ALDH1A1 4869/4885KMT2A 2218/4885ESR1 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.